Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cameroon
Cape Verde
Central Afr. Rep.
Chad
Comoros
Congo (Brazzaville)
Congo (Kinshasa)
C�te d'Ivoire
Djibouti
Egypt
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Lesotho
Liberia
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
São Tomé
Senegal
Seychelles
Sierra Leone
Somalia
South Africa
South Sudan
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Western Sahara
Zambia
Zimbabwe
|
Get AfricaFocus Bulletin by e-mail!
Print this page
Note: This document is from the archive of the Africa Policy E-Journal, published
by the Africa Policy Information Center (APIC) from 1995 to 2001 and by Africa Action
from 2001 to 2003. APIC was merged into Africa Action in 2001. Please note that many outdated links in this archived
document may not work.
|
USA: Global Infectious Disease Threat
USA: Global Infectious Disease Threat
Date distributed (ymd): 000505
Document reposted by APIC
+++++++++++++++++++++Document Profile+++++++++++++++++++++
Region: Continent-Wide
Issue Areas: +economy/development+
Summary Contents:
The posting contains brief excerpts taken from National
Intelligence Estimate 99-17D, of January 2000, which frames
infectious diseases such as HIV/AIDS as a national security
threat to the U.S. For the full text of the unclassified
report, see
http://www.cia.gov/cia/publications/nie/report/nie99-17d.html
An article in the Washington Post (April 29, 2000) reported
that the Clinton administration has now formally determined
that HIV/AIDS poses a national security threat.
A related posting today provides updates on malaria, ranked by
the report as third most deadly behind HIV/AIDS and TB.
+++++++++++++++++end profile++++++++++++++++++++++++++++++
The Global Infectious Disease Threat and Its Implications for
the United States
NIE 99-17D, January 2000
This report represents an important initiative on the part of
the Intelligence Community to consider the national security
dimension of a nontraditional threat. It responds to a growing
concern by senior US leaders about the implications--in terms
of health, economics, and national security--of the growing
global infectious disease threat. The dramatic increase in
drug-resistant microbes, combined with the lag in development
of new antibiotics, the rise of megacities with severe health
care deficiencies, environmental degradation, and the growing
ease and frequency of cross-border movements of people and
produce have greatly facilitated the spread of infectious
diseases. ...
As part of this new US Government effort, the National
Intelligence Council produced this National Intelligence
Estimate. It examines the most lethal diseases globally and by
region; develops alternative scenarios about their future
course; examines national and international capacities to deal
with them; and assesses their national and global social,
economic, political, and security impact. ...
- Of the seven biggest killers worldwide, TB, malaria,
hepatitis, and, in particular, HIV/AIDS continue to surge,
with HIV/AIDS and TB likely to account for the overwhelming
majority of deaths from infectious diseases in developing
countries by 2020. ...
- Sub-Saharan Africa--accounting for nearly half of infectious
disease deaths globally--will remain the most vulnerable
region. The death rates for many diseases, including HIV/AIDS
and malaria, exceed those in all other regions. Sub-Saharan
Africa's health care capacity--the poorest in the world--will
continue to lag. ...
The most likely scenario, in our view, is one in which the
infectious disease threat--particularly from HIV/AIDS--worsens
during the first half of our time frame, but decreases
fitfully after that, owing to better prevention and control
efforts, new drugs and vaccines, and socioeconomic
improvements. In the next decade, under this scenario,
negative demographic and social conditions in developing
countries, such as continued urbanization and poor health care
capacity, remain conducive to the spread of infectious
diseases; persistent poverty sustains the least developed
countries as reservoirs of infection; and microbial resistance
continues to increase faster than the pace of new drug and
vaccine development. During the subsequent decade, more
positive demographic changes such as reduced fertility and
aging populations; gradual socioeconomic improvement in most
countries; medical advances against childhood and
vaccine-preventable killers such as diarrheal diseases,
neonatal tetanus, and measles; expanded international
surveillance and response systems; and improvements in
national health care capacities take hold in all but the least
developed countries. Barring the appearance of a deadly and
highly infectious new disease, a catastrophic upward lurch by
HIV/AIDS, or the release of a highly contagious biological
agent capable of rapid and widescale secondary spread, these
developments produce at least limited gains against the
overall infectious disease threat. However, the remaining
group of virulent diseases, led by HIV/AIDS and TB, continue
to take a significant toll. ...
The persistent infectious disease burden is likely to
aggravate and, in some cases, may even provoke economic decay,
social fragmentation, and political destabilization in the
hardest hit countries in the developing and former communist
worlds ...
- The economic costs of infectious diseases--especially
HIV/AIDS and malaria--are already significant, and their
increasingly heavy toll on productivity, profitability, and
foreign investment will be reflected in growing GDP losses, as
well, that could reduce GDP by as much as 20 percent or more
by 2010 in some Sub-Saharan African countries, according to
recent studies.
- Some of the hardest hit countries in Sub-Saharan Africa--and
possibly later in South and Southeast Asia--will face a
demographic upheaval as HIV/AIDS and associated diseases
reduce human life expectancy by as much as 30 years and kill
as many as a quarter of their populations over a decade or
less, producing a huge orphan cohort. Nearly 42 million
children in 27 countries will lose one or both parents to AIDS
by 2010; 19 of the hardest hit countries will be in
Sub-Saharan Africa.
The relationship between disease and political instability is
indirect but real. A wide-ranging study on the causes of state
instability suggests that infant mortality--a good indicator
of the overall quality of life--correlates strongly with
political instability, particularly in countries that already
have achieved a measure of democracy. The severe social and
economic impact of infectious diseases is likely to intensify
the struggle for political power to control scarce state
resources. ...
A Word About Data
All data concerning global disease incidence, including WHO
data, should be treated as broadly indicative of trends rather
than accurate measures of disease prevalence. Much disease
incidence in developing countries, in particular, is either
unreported or under-reported ... Since much morbidity and
mortality are multicausal, moreover, diagnosis and reporting
of diseases can vary and further distort comparisons. WHO and
other international entities are dependent on such data
despite its weaknesses and are often forced to extrapolate or
build models based on relatively small samples, as in the case
of HIV/AIDS. ...
The Deadly Seven
The seven infectious diseases that caused the highest number
of deaths in 1998, according to WHO and DIA's Armed Forces
Medical Intelligence Center (AFMIC), will remain threats well
into the next century. HIV/AIDS, TB, malaria, and hepatitis B
and C--are either spreading or becoming more drug-resistant,
while lower respiratory infections, diarrheal diseases, and
measles, appear to have at least temporarily peaked ...
HIV/AIDS. Following its identification in 1983, the spread of
HIV intensified quickly. Despite progress in some regions,
HIV/AIDS shows no signs of abating globally (see figure 3).
Approximately 2.3 million people died from AIDS worldwide in
1998, up dramatically from 0.7 million in 1993, and there were
5.8 million new infections. According to WHO, some 33.4
million people were living with HIV by 1998, up from 10
million in 1990, and the number could approach 40 million by
the end of 2000. Although infection and death rates have
slowed considerably in developed countries owing to the
growing use of preventive measures and costly new multidrug
treatment therapies, the pandemic continues to spread in much
of the developing world, where 95 percent of global infections
and deaths have occurred. Sub-Saharan Africa currently has the
biggest regional burden, but the disease is spreading quickly
in India, Russia, China, and much of the rest of Asia. ...
TB. WHO declared TB a global emergency in 1993 and the threat
continues to grow, especially from multidrug resistant TB (see
figure 4). The disease is especially prevalent in Russia,
India, Southeast Asia, Sub-Saharan Africa, and parts of Latin
America. More than 1.5 million people died of TB in 1998,
excluding those infected with HIV/AIDS, and there were up to
7.4 million new cases. Although the vast majority of TB
infections and deaths occur in developing regions, the disease
also is encroaching into developed regions due to increased
immigration and travel and less emphasis on prevention. Drug
resistance is a growing problem; the WHO has reported that up
to 50 percent of people with multidrug resistant TB may die of
their infection despite treatment, which can be 10 to 50 times
more expensive than that used for drug-sensitive TB. HIV/AIDS
also has contributed to the resurgence of TB. One-quarter of
the increase in TB incidence involves co-infection with HIV.
TB probably will rank second only to HIV/AIDS as a cause of
infectious disease deaths by 2020.
Malaria, a mainly tropical disease that seemed to be coming
under control in the 1960s and 1970s, is making a deadly
comeback--especially in Sub-Saharan Africa where infection
rates increased by 40 percent from 1970 to 1997 (see figure
5). Drug resistance, historically a problem only with the most
severe form of the disease, is now increasingly reported in
the milder variety, while the prospects for an effective
vaccine are poor. In 1998, an estimated 300 million people
were infected with malaria, and more than 1.1 million died
from the disease that year. Most of the deaths occurred in
Sub-Saharan Africa. According to the US Agency for
International Development (USAID), Sub-Saharan Africa alone is
likely to experience a 7- to 20-percent annual increase in
malaria-related deaths and severe illnesses over the next
several years. ...
Sub-Saharan Africa will remain the region most affected by the
global infectious disease phenomenon--accounting for nearly
half of infectious disease-caused deaths worldwide. Deaths
from HIV/AIDS, malaria, cholera, and several lesser known
diseases exceed those in all other regions. Sixty-five percent
of all deaths in Sub-Saharan Africa are caused by infectious
diseases. Rudimentary health care delivery and response
systems, the unavailability or misuse of drugs, the lack of
funds, and the multiplicity of conflicts are exacerbating the
crisis. According to the AFMIC typology, with the exception of
southern Africa, most of Sub-Saharan Africa falls in the
lowest category. Investment in health care in the region is
minimal, less than 40 percent of the people in countries such
as Nigeria and the Democratic Republic of the Congo (DROC)
have access to basic medical care, and even in relatively well
off South Africa, only 50 to 70 percent have such access, with
black populations at the low end of the spectrum.
Four-fifths of all HIV-related deaths and 70 percent of new
infections worldwide in 1998 occurred in the region, totaling
1.8-2 million and 4 million, respectively. Although only a
tenth of the world's population lives in the region, 11.5
million of 13.9 million cumulative AIDS deaths have occurred
there. Eastern and southern African countries, including South
Africa, are the worst affected, with 10 to 26 percent of
adults infected with the disease. Sub-Saharan Africa has high
TB prevalence, as well as the highest HIV/TB co-infection
rate, with TB deaths totaling 0.55 million in 1998. The
hardest hit countries are in equatorial and especially
southern Africa. South Africa, in particular, is facing the
biggest increase in the region.
Sub-Saharan Africa accounts for an estimated 90 percent of the
global malaria burden (see figure 10). Ten percent of the
regional disease burden is attributed to malaria, with roughly
1 million deaths in 1998. Cholera, dysentery, and other
diarrheal diseases also are major killers in the region,
particularly among children, refugees, and internally
displaced populations. Forty percent of all childhood deaths
from diarrheal diseases occur in Sub-Saharan Africa. The
region also has a high rate of hepatitis B and C infections
and is the only region with a perennial meningococcal
meningitis problem in a "meningitis belt" stretching from west
to east. ...
Middle East and North Africa
The region's conservative social mores, climatic factors, and
high levels of health spending in oil-producing states tend to
limit some globally prevalent diseases, such as HIV/AIDS and
malaria, but others, such as TB and hepatitis B and C, are
more prevalent. The region's advantages are partially offset
by the impact of war-related uprooting of populations,
overcrowded cities with poor refrigeration and sanitation
systems, and a dearth of water, especially clean drinking
water. ...
The HIV/AIDS impact is far lower than in other regions, with
210,000 cases, or 0.13 percent of the population, including
19,000 new cases, in 1998. This owes in part to above-average
underreporting because of the stigma associated with the
disease in Muslim societies and the authoritarian nature of
most governments in the region. ...
International Response Capacity
International organizations such as WHO and the World Bank,
institutions in several developed countries such as the US
CDC, and Nongovernmental Organizations (NGOs) will continue to
play an important role in strengthening both international and
national surveillance and response systems for infectious
diseases. Nonetheless, progress is likely to be slow, and
development of an integrated global surveillance and response
system probably is at least a decade or more away. This owes
to the magnitude of the challenge; inadequate coordination at
the international level; and lack of funds, capacity, and, in
some cases, cooperation and commitment at the national level.
Some countries hide or understate their infectious disease
problems for reasons of international prestige and fear of
economic losses. Total international health-related aid to
low- and middle-income countries--some $2-3 billion
annually--remains a fraction of the $250 billion health bill
of these countries. ...
Macroeconomic Impact The macroeconomic costs of the infectious
disease burden are increasingly significant for the most
seriously affected countries despite the partially offsetting
impact of declines in population growth, and they will take an
even greater toll on productivity, profitability, and foreign
investment in the future. A senior World Bank official
considers AIDS to be the single biggest threat to economic
development in Sub-Saharan Africa. A growing number of studies
suggest that AIDS and malaria alone will reduce GDP in several
Sub-Saharan African countries by 20 percent or more by 2010.
- The impact of infectious diseases on annual GDP growth in
heavily affected countries already amounts to as much as a
1-percentage point reduction in the case of HIV/AIDS on
average and 1 to 2 percentage points for malaria, according to
World Bank studies. A recent Namibian study concluded that
AIDS cost the country nearly 8 percent of GDP in 1996, while
a study of Kenya projected that GDP will be 14.5 percent
smaller in 2005 than it otherwise would have been without the
cumulative impact of AIDS. The annual cost of malaria to
Kenya's GDP was estimated at 2 to 6 percent and at 1 to 5
percent for Nigeria. ...
- Public health spending on AIDS and related diseases
threatens to crowd out other types of health care and social
spending. ... In Kenya, HIV/AIDS treatment costs are projected
to account for 50 percent of health spending by 2005. In South
Africa, such costs could account for 35 to 84 percent of
public health expenditures by 2005, according to one
projection.
Disruptive Social Impact
At least some of the hardest-hit countries, initially in
Sub-Saharan Africa and later in other regions, will face a
demographic catastrophe as HIV/AIDS and associated diseases
reduce human life expectancy dramatically and kill up to a
quarter of their populations over the period of this Estimate
(see table 5). ...
Life Expectancy and Population Growth. Until the early 1990s,
economic development and improved health care had raised the
life expectancy in developing countries to 64 years, with
prospects that it would go higher still. The growing number of
deaths from new and reemergent diseases such as AIDS, however,
will slow or reverse this trend toward longer life spans in
heavily affected countries by as much as 30 years or more by
2010, according to the US Census Bureau. For example, life
expectancy will be reduced by 30 years in Botswana and
Zimbabwe, by 20 years in Nigeria and South Africa, by 13 years
in Honduras, by eight years in Brazil, by four years in Haiti,
and by three years in Thailand. ...
Family Structure. The degradation of nuclear and extended
families across all classes will produce severe social and
economic dislocations with political consequences, as well.
Nearly 35 million children in 27 countries will have lost one
or both parents to AIDS by 2000; by 2010, this number will
increase to 41.6 million. Nineteen of the hardest hit
countries are in Sub-Saharan Africa, where HIV/AIDS has been
prevalent across all social sectors. ... With as much as a
third of the children under 15 in hardest-hit countries
expected to comprise a "lost orphaned generation" by 2010 with
little hope of educational or employment opportunities, these
countries will be at risk of further economic decay, increased
crime, and political instability as such young people become
radicalized or are exploited by various political groups for
their own ends; the pervasive child soldier phenomenon may be
one example.
Destabilizing Political and Security Impact In our view, the
infectious disease burden will add to political instability
and slow democratic development in Sub-Saharan Africa, parts
of Asia, and the former Soviet Union, while also increasing
political tensions in and among some developed countries.
The severe social and economic impact of infectious
diseases, particularly HIV/AIDS, and the infiltration of these
diseases into the ruling political and military elites and
middle classes of developing countries are likely to intensify
the struggle for political power to control scarce state
resources. This will hamper the development of a civil society
and other underpinnings of democracy and will increase
pressure on democratic transitions in regions such as the FSU
and Sub-Saharan Africa where the infectious disease burden
will add to economic misery and political polarization.
This material is being reposted for wider distribution by the
Africa Policy Information Center (APIC). APIC's primary
objective is to widen international policy debates around
African issues, by concentrating on providing accessible
policy-relevant information and analysis usable by a wide
range of groups and individuals.
|